Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
M. Karthaus, A. Kretzschmar, H. Kröning, M. Biakhov +11 more
2006Annals of Oncology235 citations Open access
Semantic Scholar

